Chemotherapy

What is it?
  • The use of specific drugs to treat cancer.
  • Normally used to treat recurring or metastatic prostate cancer if hormone therapy does not work anymore.
  • Chemotherapy drugs affect both cancer cells and healthy cells. Healthy cells tend to regenerate whereas cancer cells struggle to do so.
  • It is sometimes used to treat more advanced cancer in conjunction with surgical removal of the prostate.
For more information about chemotherapy drugs visit our Prostate Cancer Drugs page.

What is done?

Chemotherapy is usually given through the vein but some forms can be taken as a pill.

 
What to expect?

Chemotherapy is typically used to slow the prostate cancer’s spread, prolong life, and relieve pain associated with the late stages of cancer.


Side effects and risks

Specific side-effects depend on the type of drugs that are given. The following side-effects are common with most types of chemotherapy:
  • Gastrointestinal side-effects such as nausea, vomiting and diarrhea
  • Anemia
  • Total or partial hair loss
  • Sensitive skin
  • Infertility
  • Vulnerability to infection (most commonly chest, mouth, throat and urinary infections)
  • Nail changes
Some side-effects can be treated with other drugs; others continue until chemotherapy is stopped.


 

For more information and support:





Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Rocco Rossi to wrap up successful 5-year tenure as Prostate Cancer Canada CEO

September 7, 2017 - TORONTO, ON - With mixed emotions, longstanding Prostate Cancer Canada (PCC) President and CEO, Rocco Rossi, formally announced today that his time leading the organization will officially come to a close as of December 31, 2017.
More

Mutation in prostate tumours shown to change epigenetic identity, the make-up of DNA

(TORONTO, Canada - Aug 7, 2017) -- Prostate cancer researchers have mapped the impact of an acquired mutation that alters epigenetic identity, the make-up of DNA, in about 50% of patient tumour samples.
More

Movember Foundation and Prostate Cancer Canada team up to turn research into results

July 26, 2017 - TORONTO, ON - Continuing their longstanding tradition of partnering to fund high quality Canadian prostate cancer research, Prostate Cancer Canada (PCC) and The Movember Foundation today announced two new projects with very real potential to make a tangible difference in the lives of men living with aggressive forms of prostate cancer.
More


Click here for news archive